Investment Rating - The investment rating for the company is "Buy" with a target price set for the next six months [6][16]. Core Insights - The company reported a strong performance in H1 2025, with revenue of 3.478 billion yuan, a year-on-year increase of 4.75%, and a net profit attributable to shareholders of 266 million yuan, up 11.66% year-on-year [1]. - The beauty segment continues to grow, with H1 2025 revenue of 747 million yuan, a 32.05% increase year-on-year, while the personal care segment saw revenue of 1.590 billion yuan, a slight increase of 0.10% year-on-year [3]. - The company is consolidating its core brand advantages, with significant growth in its leading brands, such as Liushen and Yuze, and a strong recovery in the herbal brand Bai Caoshu [4]. Financial Performance - In H1 2025, the gross margin was 63.37%, an increase of 2.24 percentage points year-on-year, and the net profit margin was 7.64%, up 0.47 percentage points year-on-year [2]. - The company expects revenue for 2025-2027 to be 6.238 billion, 6.868 billion, and 7.638 billion yuan respectively, with net profits projected at 374 million, 491 million, and 573 million yuan [4]. Brand Development - The first-tier brands, Liushen and Yuze, have shown significant online growth, with Liushen launching a new portable mosquito repellent product that topped sales on Tmall [4]. - The second-tier brand Bai Caoshu has seen over 50% revenue growth in H1 2025, driven by successful product launches and promotions [4].